PT1379650E - Segmentos preferidos da proteina de cadeia neuronal ntp e procedimentos para a sua utilizacao. - Google Patents
Segmentos preferidos da proteina de cadeia neuronal ntp e procedimentos para a sua utilizacao.Info
- Publication number
- PT1379650E PT1379650E PT01988772T PT01988772T PT1379650E PT 1379650 E PT1379650 E PT 1379650E PT 01988772 T PT01988772 T PT 01988772T PT 01988772 T PT01988772 T PT 01988772T PT 1379650 E PT1379650 E PT 1379650E
- Authority
- PT
- Portugal
- Prior art keywords
- procedures
- ntp
- chain protein
- preferred
- preferred segments
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/697,590 US7259232B1 (en) | 2000-10-27 | 2000-10-27 | Preferred segments of neural thread protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1379650E true PT1379650E (pt) | 2006-10-31 |
Family
ID=24801714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01988772T PT1379650E (pt) | 2000-10-27 | 2001-10-25 | Segmentos preferidos da proteina de cadeia neuronal ntp e procedimentos para a sua utilizacao. |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7259232B1 (pt) |
| EP (2) | EP1379650B1 (pt) |
| JP (1) | JP2005512500A (pt) |
| KR (1) | KR100843792B1 (pt) |
| CN (1) | CN1492926A (pt) |
| AT (1) | ATE330011T1 (pt) |
| AU (1) | AU2002232392A1 (pt) |
| BR (1) | BR0114977A (pt) |
| CA (1) | CA2427070A1 (pt) |
| CY (1) | CY1105380T1 (pt) |
| DE (1) | DE60120782T2 (pt) |
| DK (1) | DK1379650T3 (pt) |
| ES (1) | ES2266296T3 (pt) |
| PT (1) | PT1379650E (pt) |
| WO (1) | WO2002034915A2 (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002302239B2 (en) * | 2000-10-27 | 2006-12-14 | Nymox Corporation | Method of preventing cell death using segments of neural thread proteins |
| ATE300951T1 (de) * | 2001-05-16 | 2005-08-15 | Nymox Corp | Prävention des zelltodes durch verwendung der segmente der neurofilamentproteine |
| EP1541166B1 (en) * | 2001-05-16 | 2007-12-19 | Nymox Corporation | Preventing cell death using segments of neural thread proteins |
| BR0209990A (pt) * | 2001-05-25 | 2004-06-29 | Nymox Corp | Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células |
| US7544771B2 (en) * | 2005-02-23 | 2009-06-09 | Nymox Corporation | Protein and its use in diagnosing Alzheimer's disease |
| US11628202B2 (en) | 2015-07-24 | 2023-04-18 | Nymox Corporation | Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia |
| US10183058B2 (en) | 2016-06-17 | 2019-01-22 | Nymox Corporation | Method of preventing or reducing the progression of prostate cancer |
| US10172910B2 (en) | 2016-07-28 | 2019-01-08 | Nymox Corporation | Method of preventing or reducing the incidence of acute urinary retention |
| US10532081B2 (en) | 2016-09-07 | 2020-01-14 | Nymox Corporation | Method of ameliorating or preventing the worsening or the progression of symptoms of BPH |
| US10335453B2 (en) | 2017-03-01 | 2019-07-02 | Nymox Corporation | Compositions and methods for improving sexual function |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0068375A3 (en) | 1981-06-22 | 1983-04-13 | G.D. Searle & Co. | Recombinant dna techniques for the production of relaxin |
| SE8300693L (sv) | 1983-02-09 | 1984-08-10 | Sven Lofdahl | Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5084559A (en) | 1987-03-27 | 1992-01-28 | Repligen Corporation | Protein a domain mutants |
| US5948634A (en) | 1988-12-21 | 1999-09-07 | The General Hospital Coporation | Neural thread protein gene expression and detection of alzheimer's disease |
| CA2006332C (en) | 1988-12-21 | 2003-04-08 | Suzanne De La Monte | Method of detecting neurological disease or dysfunction |
| US5556781A (en) * | 1994-03-07 | 1996-09-17 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparations and uses |
| GB9422175D0 (en) | 1994-11-03 | 1994-12-21 | Univ Dundee | Indentification of the p21 waf1-pcna interaction site and therapeutic applications thereof |
| US5958416A (en) | 1994-12-16 | 1999-09-28 | Regents Of The University Of Minnesota | Heat shock protein peptides and methods for modulating autoimmune central nervous system disease |
| US6610506B1 (en) * | 1995-12-01 | 2003-08-26 | University Technologies International, Inc. | Transferrin binding proteins of Pasteurella haemolytica and vaccines containing same |
| US6013763A (en) | 1996-06-04 | 2000-01-11 | Genentech, Inc. | Peptide variants of protein A |
| EP1030819A4 (en) | 1997-09-30 | 2001-11-21 | Cel Sci Corp | IMMUNOGENOUS CONJUGATED POLYPEPTIDES FOR THE TREATMENT OF HERPES-SIMPLEX VIRUS |
| AU4859399A (en) | 1998-07-02 | 2000-01-24 | President And Fellows Of Harvard College | Compositions and methods for treating papillomavirus-infected cells |
| WO2000055198A1 (en) | 1999-03-12 | 2000-09-21 | Human Genome Sciences, Inc. | 50 human secreted proteins |
| JP2002539842A (ja) | 1999-03-26 | 2002-11-26 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | ４５個のヒト分泌タンパク質 |
| ATE300951T1 (de) | 2001-05-16 | 2005-08-15 | Nymox Corp | Prävention des zelltodes durch verwendung der segmente der neurofilamentproteine |
-
2000
- 2000-10-27 US US09/697,590 patent/US7259232B1/en not_active Expired - Lifetime
-
2001
- 2001-10-25 KR KR1020037005830A patent/KR100843792B1/ko not_active IP Right Cessation
- 2001-10-25 BR BRPI0114977-6A patent/BR0114977A/pt not_active IP Right Cessation
- 2001-10-25 CA CA002427070A patent/CA2427070A1/en not_active Abandoned
- 2001-10-25 AU AU2002232392A patent/AU2002232392A1/en not_active Abandoned
- 2001-10-25 DE DE60120782T patent/DE60120782T2/de not_active Expired - Lifetime
- 2001-10-25 PT PT01988772T patent/PT1379650E/pt unknown
- 2001-10-25 ES ES01988772T patent/ES2266296T3/es not_active Expired - Lifetime
- 2001-10-25 EP EP01988772A patent/EP1379650B1/en not_active Expired - Lifetime
- 2001-10-25 CN CNA018212131A patent/CN1492926A/zh active Pending
- 2001-10-25 EP EP06115298A patent/EP1702985A3/en not_active Withdrawn
- 2001-10-25 DK DK01988772T patent/DK1379650T3/da active
- 2001-10-25 WO PCT/US2001/042813 patent/WO2002034915A2/en active IP Right Grant
- 2001-10-25 AT AT01988772T patent/ATE330011T1/de not_active IP Right Cessation
- 2001-10-25 JP JP2002537885A patent/JP2005512500A/ja active Pending
-
2006
- 2006-09-12 CY CY20061101300T patent/CY1105380T1/el unknown
-
2007
- 2007-07-23 US US11/878,288 patent/US20090258426A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20090258426A1 (en) | 2009-10-15 |
| JP2005512500A (ja) | 2005-05-12 |
| ATE330011T1 (de) | 2006-07-15 |
| US7259232B1 (en) | 2007-08-21 |
| CY1105380T1 (el) | 2010-04-28 |
| WO2002034915A2 (en) | 2002-05-02 |
| EP1702985A3 (en) | 2007-03-07 |
| ES2266296T3 (es) | 2007-03-01 |
| WO2002034915A3 (en) | 2003-11-20 |
| KR100843792B1 (ko) | 2008-07-03 |
| DE60120782T2 (de) | 2007-05-24 |
| DK1379650T3 (da) | 2006-10-23 |
| KR20030067681A (ko) | 2003-08-14 |
| EP1379650B1 (en) | 2006-06-14 |
| CA2427070A1 (en) | 2002-05-02 |
| DE60120782D1 (de) | 2006-07-27 |
| BR0114977A (pt) | 2006-05-09 |
| EP1702985A2 (en) | 2006-09-20 |
| EP1379650A2 (en) | 2004-01-14 |
| AU2002232392A1 (en) | 2002-05-06 |
| CN1492926A (zh) | 2004-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1105380T1 (el) | Προτιμωμενα τμηματα της νευρικης νηματικης πρωτεϊνης και μεθοδοι χρησης αυτων | |
| BR0111125A (pt) | Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos | |
| CY1116256T1 (el) | Il-17 ανταγωνιστικα αντισωματα | |
| PT1171465E (pt) | Analogos de petido inibidor gastrico e sua utilizacao para o tratamento de diabetes | |
| CY1109981T1 (el) | Αναλογα του gaba για την προληψη και αγωγη γαστρεντερικης βλαβης | |
| UY27062A1 (es) | Anticuerpos humanizados que reconocen el peptido amiloideo beta | |
| PT966436E (pt) | Arilsulfonamidas e analogos e sua aplicacao para o tratamento de doencas neurodegenerativas | |
| DK1434791T3 (da) | Specifikke bindingsmidler til human angiopoietin-2 | |
| EE9900492A (et) | II tüüpi TGF-ß retseptori/immunoglobuliini konstantse piirkonna hübriidvalgud | |
| NZ263344A (en) | Human bactericidal/permeability increasing (bpi) protein functional domain peptides and their use | |
| DK2356996T3 (da) | Behandling af alzheimer's sygdom | |
| PT840615E (pt) | Proteina de ligacao da quemoquina e metodos para a sua utilizacao | |
| DE69833014D1 (de) | Menschliche toll homologen | |
| ES2116298T3 (es) | Nuevo metodo de tratamiento de la depresion. | |
| DE69704737D1 (de) | Amphotere Polymere zur Lederbehandlung | |
| DK0845034T3 (da) | Peptid med pronociceptive egenskaber | |
| PA8613101A1 (es) | Aminoacidos con afinidad por la proteina alfa 2 delta | |
| PT1133997E (pt) | Beta-interferao para o tratamento de doencas imunitarias | |
| ATE249172T1 (de) | Medizinisches gerät | |
| DE60319342D1 (de) | N rheumatoider arthritis | |
| EP0816498A3 (en) | Excitatory amino acid receptor protein and related nucleic acid compounds | |
| DE60139458D1 (de) | Neue menschliche g-protein gekoppelten rezeptoren und dafür kodierende polynucleotide | |
| DE60321443D1 (de) | Screening-verfahren für eine prophylaktische und therapeutische Substanz für eine Nierenerkrankung | |
| ES2185083T3 (es) | Proteina estimulante de macrofagos para el tratamiento de patologias del sistema nervioso. | |
| ATE366261T1 (de) | Humane 7-transmembranproteine und dafür codierende polynukleotide |